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Aquaporin-3 Re-Expression Induces Differentiation
in a Phospholipase D2-Dependent Manner in
Aquaporin-3-Knockout Mouse Keratinocytes
Vivek Choudhary1,2,3, Lawrence O. Olala1,2, Haixia Qin1,2,6, Inas Helwa1,2, Zhi-qiang Pan2,4, Ying-Ying Tsai2,
Michael A. Frohman5, Ismail Kaddour-Djebbar1,2 and Wendy B. Bollag1,2,3
Aquaporin-3 (AQP3) is a water and glycerol channel expressed in epidermal keratinocytes. Despite many studies,
controversy remains about the role of AQP3 in keratinocyte differentiation. Previously, our laboratory has shown
co-localization of AQP3 and phospholipase D2 (PLD2) in caveolin-rich membrane microdomains. We hypothe-
sized that AQP3 transports glycerol and ‘‘funnels’’ this primary alcohol to PLD2 to form a pro-differentiative signal,
such that the action of AQP3 to induce differentiation should require PLD2. To test this idea, we re-expressed
AQP3 in mouse keratinocytes derived from AQP3-knockout mice. The re-expression of AQP3, which increased
[3H]glycerol uptake, also induced mRNA and protein expression of epidermal differentiation markers such as
keratin 1, keratin 10, and loricrin, with or without the induction of differentiation by an elevated extracellular
calcium concentration. Re-expression of AQP3 had no effect on the expression of the proliferation markers
keratin 5 and cyclin D1. Furthermore, a selective inhibitor of PLD2, CAY10594, and a lipase-dead (LD) PLD2 mutant,
but not a LD PLD1 mutant, significantly inhibited AQP3 re-expression–induced differentiation marker expression
with calcium elevation, suggesting a role for PLD2 in this process. Thus, our results indicate that AQP3 has a pro-
differentiative role in epidermal keratinocytes and that PLD2 activity is necessary for this effect.
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INTRODUCTION
The outer layer of the skin, the epidermis, is a stratified
squamous epithelium that predominantly consists of keratin-
producing cells, the keratinocytes. These keratinocytes form
different layers of the epidermis depending on their prolifera-
tion and differentiation status. In the basal layer, keratinocytes
proliferate and express markers of a proliferative status, such
as keratin 5 and keratin 14. These keratinocytes move upward
and form the differentiating spinous, granular, and cornified
layers. The keratinocytes in the spinous layer express markers
of early differentiation such as keratin 1 (K1) and keratin 10
(K10). These spinous keratinocytes later express markers of
intermediate differentiation such as involucrin, whereas the
keratinocytes that move up into the granular layer express
markers of late differentiation such as loricrin (LOR) and
filaggrin. The transition of granular keratinocytes into cornified
keratinocytes, forming the outermost cornified layer, is marked
by destruction of organelles and maturation of the cornified
envelope into an insoluble, highly resistant structure surround-
ing the keratin–filaggrin complex and linked to the extracel-
lular lipid milieu (Bikle and Pillai, 1993). Thus, the cornified
layer provides a protective skin barrier to allow retention of
water and other important metabolites. These programmed
and balanced processes of proliferation and differentiation are
therefore important in maintaining skin health. Although there
have been many studies performed to elucidate the regulation
of these proliferation and differentiation processes, the exact
regulators and signaling mechanism(s) underlying these events
are still unclear. One of the well-known regulators of
epidermal differentiation is the extracellular calcium concen-
tration, with lower concentrations maintaining a proliferative
state and elevated levels inducing differentiation (Tu and
Bikle, 2013).
Aquaporins are a family of transmembrane proteins that
facilitate the transport of water, and in some cases small
solutes, across cell membranes (Verkman, 2008). Thirteen
aquaporins have been identified to date, and the expression of
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aquaporins 3, 9, and 10 has been reported in the epidermis
(Sugiyama et al., 2001; Ma et al., 2002; Sougrat et al., 2002;
Boury-Jamot et al., 2006). Aquaporin 3 (AQP3) not only
transports water but also allows movement of small solutes
like glycerol across the plasma membrane (Hara and
Verkman, 2003; Hara-Chikuma and Verkman, 2005). In
mammalian skin, AQP3 is expressed in the basal layer as
well as in the suprabasal layers of the epidermis (Verkman and
Mitra, 2000; Hara-Chikuma and Verkman, 2008; Lee et al.,
2012; Guo et al., 2013), whereas its presence in the stratum
corneum is controversial (Sougrat et al., 2002; Jungersted
et al., 2013). Studies characterizing AQP3-knockout mice
suggest that this aquaglyceroporin is required for maintaining
normal stratum corneum hydration, skin elasticity, wound
healing, epidermal biosynthesis, and barrier recovery (Ma
et al., 2002; Hara-Chikuma and Verkman, 2008). AQP3 has
been shown to be involved in keratinocyte proliferation (Hara-
Chikuma et al., 2009; Nakahigashi et al., 2011; Serna et al.,
2014) as well as in keratinocyte differentiation (Dumas et al.,
2002; Zheng and Bollag, 2003; Bollag et al., 2007; Kim and
Lee, 2010). The epidermal phenotype of AQP3-knockout
mice is linked to decreased epidermal glycerol content and
can be corrected by treatment with glycerol but not with
other humectants (Ma et al., 2002). These reports highlight
the importance of glycerol and its transport channel in
keratinocyte physiology.
The phospholipase D (PLD) isoforms PLD1 and PLD2 are
lipolytic enzymes that have been implicated in a variety of
cellular processes, including cell proliferation and differentia-
tion (Banno, 2002; Jenkins and Frohman, 2005; Di Fulvio
et al., 2012). PLD2 hydrolyzes phosphatidylcholine to
produce choline and phosphatidic acid, or, in the presence
of a primary alcohol, catalyzes a transphosphatidylation reac-
tion to produce phosphatidylalcohols. Our laboratory has
previously demonstrated that PLD2 can use glycerol in the
transphosphatidylation reaction to form phosphatidylglycerol
(Zheng et al., 2003), a largely unrecognized lipid signal, and
that this signaling module/lipid shows pro-differentiative
effects in keratinocytes ((Bollag et al., 2007) and reviewed in
(Qin et al., 2011)).
Considering the importance of regulators of proliferation
and differentiation processes in maintaining the normal func-
tion of the skin, there is a need to further define the role of
AQP3 in keratinocytes and to identify the mechanisms under-
lying its effects in the epidermis. Here, we have re-expressed
AQP3 in AQP3-knockout keratinocytes and determined the
effect of this manipulation on proliferative and differentiative
processes. We hypothesized that AQP3 increases glycerol
transport and ‘‘funnels’’ this primary alcohol to PLD2 such that
its effects on differentiation are mediated by PLD2.
RESULTS
Validation of expression and activity of re-expressed AQP3 in
AQP3-knockout keratinocytes
To better understand the role of AQP3 in keratinocytes, we
utilized an approach that involved re-expression of wild-type
AQP3 in keratinocytes derived from AQP3-knockout mice.
We first confirmed the re-expression of AQP3 protein upon
adenoviral infection. There was significant re-expression of
AQP3 protein in keratinocytes infected with adenovirus
expressing AQP3 as compared with vector-infected keratino-
cytes (Figure 1a). The diffuse band around 35–40 kDa repre-
sents glycosylated AQP3 (Boury-Jamot et al., 2006), which
suggests that the re-expressed AQP3 was able to localize to
the plasma membrane and function as a transporter. As AQP3
has been shown to be important for transporting glycerol into
keratinocytes, the functionality of re-expressed AQP3 was
further confirmed by measuring [3H]glycerol uptake by these
cells. As shown in Figure 1b, cells re-expressing AQP3
exhibited significantly increased glycerol uptake. These results
confirmed the validity of our re-expression approach.
AQP3 re-expression increases expression of differentiation
markers in AQP3-knockout keratinocytes
Once we confirmed the re-expression and activity of AQP3 in
AQP3-knockout keratinocytes, we then investigated the role/
effect of re-expressed AQP3 in these cells. To better under-
stand the effect of the re-expressed AQP3 on various differ-
entiation and proliferation markers, we treated one set of cells
with a moderately increased calcium concentration to stimu-
late keratinocyte differentiation. The mRNA expression of the
early differentiation marker, K1, was significantly increased in
AQP3-re-expressing keratinocytes (Figure 2a). Under differen-
tiating conditions (treatment with 125mM calcium), mRNA
levels of both early (K1 and K10) and late differentiation
markers (LOR) were significantly increased in AQP3-re-
expressing keratinocytes compared with AQP3-null keratino-
cytes (Figure 2a–c). Consistent with the changes in mRNA
expression, the protein levels of K10 and LOR were also
significantly increased upon AQP3 re-expression (Figure 2d
and e). These results clearly suggested a pro-differentiative role
for AQP3 in mouse keratinocytes.
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Figure 1. Validation of expression and activity of re-expressed aquaporin 3
(AQP3) in AQP3-knockout keratinocytes. Primary cultures of AQP3-knockout
keratinocytes were allowed to reach approximately 70–80% confluence and
then infected with adenoviruses expressing either wild-type AQP3 or vector
alone using a multiplicity of infection of 25 for 24 hours. Fresh control medium
(50mM calcium) or medium containing 125mM calcium was added for another
24 hours. (a) Total cell lysates were analyzed by western blotting using
antibodies against AQP3 and the glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) loading control. AQP3 is seen as a non-glycosylated, 28-kDa band
and a diffuse band at 35–40 kDa, representing the glycosylated form. The figure
shown is representative of three independent experiments. (b) [3H]glycerol
uptake by the cells is shown as cpmmg1 protein. The data represent the
means±SEM from three independent experiments. *Po0.05 versus
vector-infected keratinocytes.
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AQP3 re-expression has no effect on expression of markers of
keratinocyte proliferation
As earlier reports suggested a pro-proliferative role for AQP3
in keratinocytes (Hara-Chikuma et al., 2009; Nakahigashi
et al., 2011; Serna et al., 2014), we investigated the effect of
re-expressed AQP3 on proliferation markers. As shown in
Figure 3, the presence or absence of AQP3 had no significant
effect on the mRNA expression of the proliferation markers,
keratin 5 and cyclin D1. These results suggest that AQP3 does
not have a significant role in the proliferation of keratinocytes,
at least under these conditions.
The PLD2 inhibitor, CAY10594, inhibits the AQP3
re-expression–induced expression of markers of keratinocyte
differentiation
As our results demonstrated a pro-differentiative role for
re-expressed AQP3 in keratinocytes, we sought to identify
the possible downstream signaling pathway involved. Earlier
reports from our laboratory have shown that the PLD2/AQP3
module is activated by a moderately elevated calcium
concentration and suggested the involvement of this module
in promoting early keratinocyte differentiation (Zheng et al.,
2003; Bollag et al., 2007). Therefore, we investigated the
role of PLD2 in AQP3 re-expression–induced keratinocyte
differentiation. We used the PLD2-selective inhibitor,
CAY10594, at a dose previously shown to selectively inhibit
PLD2 in intact cells (Scott et al., 2009). In an earlier report, we
demonstrated the effectiveness of CAY10594 in inhibiting PLD
activity in keratinocytes, and in the same study we showed
that treatment with this concentration of CAY10594 has no
cytotoxic effect on keratinocytes (Arun et al., 2013). Treatment
of keratinocytes with this PLD2 inhibitor, together with
stimulation of differentiation with an elevated calcium
concentration, resulted in a significant inhibition of the
AQP3 re-expression–induced expression of the early
differentiation markers, K1 and K10 (Figure 4a and b). The
protein levels of K10 also correlated with the mRNA results
(Figure 5a). We did not observe statistically significant
differences in the mRNA expression of LOR (Figure 4c).
However, western blotting analysis showed that the increased
LOR protein levels were significantly reduced by CAY10594
treatment in AQP3-re-expressing keratinocytes under con-
ditions of an elevated extracellular calcium concentration
(Figure 5b). These results suggest that the ability of AQP3
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Figure 2. Aquaporin 3 (AQP3) re-expression increases the expression of differentiation markers in AQP3-knockout keratinocytes. Keratinocytes from AQP3-
knockout neonatal mice were treated as described in Figure 1. Cells were harvested for quantitative real-time reverse-transcriptase–PCR analysis of the expression
of (a) keratin 1 (K1), (b) keratin 10 (K10), and (c) loricrin (LOR). Expression was analyzed with the delta–delta cycle threshold method using an average value of
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and ribosomal protein, large, P0 as endogenous controls, and values are shown as the fold over the vector-
infected group. (d, e) Cells were harvested for western blotting analysis using antibodies against (d) K10 and (e) LOR with GAPDH as the loading control.
Quantitation of the values from three independent experiments is shown, with values expressed as the percent (%) maximal response. *Po0.05, **Po0.01
compared with the vector-infected group and the other indicated groups (in panel d); w or #Po0.05 versus the indicated groups.
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re-expression to induce differentiation depends upon PLD2
activity.
Lipase-dead (LD) PLD2, but not LD PLD1, inhibits the AQP3 re-
expression–induced increase in markers of keratinocyte
differentiation
To further confirm this PLD2 requirement, we utilized LD
PLD2 mutant-expressing adenovirus to inhibit endogenous
PLD2. LD PLD2 mutant expression inhibited AQP3 re-expres-
sion–induced mRNA expression of K1, K10, and LOR under
elevated calcium conditions (Figure 6a–c). Even under basal
conditions, AQP3-induced K10 expression was significantly
inhibited by overexpression of the LD PLD2 mutant
(Figure 6b). However, overexpression of the LD PLD1 mutant
did not inhibit AQP3 re-expression–mediated induction of
these differentiation markers (Figure 6d–f). These results
suggested the involvement of PLD2, but not PLD1, in AQP3-
mediated keratinocyte differentiation.
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Figure 3. Aquaporin 3 (AQP3) re-expression had no effect on the expression
of markers of keratinocyte proliferation. Keratinocytes from AQP3-knockout
neonatal mice were treated as described in Figure 1. Cells were harvested for
quantitative real-time reverse-transcriptase–PCR analysis, and the mRNA
expression of (a) keratin 5 (K5) and (b) cyclin D1 was analyzed using the delta–
delta cycle threshold method with the average of glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) and ribosomal protein, large, P0 expression as the
endogenous control. These results are shown as the fold over the vector-
infected group and were derived from the analysis of at least three independent
experiments. NS, nonsignificant.
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Figure 4. The phospholipase D2 (PLD2) inhibitor, CAY10594, inhibited the
aquaporin 3 (AQP3) re-expression–induced increase in the mRNA levels of
markers of keratinocyte differentiation. Primary AQP3-knockout mouse
keratinocytes were allowed to reach approximately 70–80% confluence and
then infected with adenoviruses expressing either wild-type AQP3 or vector
alone using an multiplicity of infection of 25 for 24 hours. Medium containing
the PLD2-selective inhibitor, CAY10594 (1mM), alone or in combination with
an elevated calcium concentration (125mM), was added to the keratinocytes for
an additional 24 hours. (a) The cells were harvested for quantitative real-time
reverse-transcriptase–PCR analysis, and the mRNA expression of (a) keratin 1
(K1), (b) keratin 10 (K10), and (c) loricrin (LOR) was determined using the
delta–delta cycle threshold method with glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) as the endogenous control. The results are shown as
the fold over the vector-infected group and were derived from at least three
independent experiments. ***Po0.001 compared with all other groups. NS,
nonsignificant.
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DISCUSSION
In this study, we determined the role of AQP3 in keratinocyte
differentiation and identified PLD2 as a mediator of an AQP3-
induced differentiative effect. Although previous studies have
suggested a role for AQP3 in keratinocytes, the results have
been controversial with both pro-differentiative (Dumas et al.,
2002; Zheng and Bollag, 2003; Kim and Lee, 2010; Matsuo
and Kawano, 2014) and pro-proliferative effects described
(Hara-Chikuma et al., 2009; Nakahigashi et al., 2011; Serna
et al., 2014). Here we have attempted to address this question
using a strategy that involved the re-expression of AQP3 in
primary cultures of keratinocytes derived from AQP3-
knockout mice using adenovirus expressing wild-type AQP3.
First, we verified the re-expression of AQP3 by western
blotting analysis (Figure 1a). The glycosylation of aquaporins
helps them to localize to the plasma membrane (Hendriks
et al., 2004), where they function to transport water and
glycerol. Thus, the presence of glycosylated AQP3 (Figure 1a)
upon adenoviral transduction of keratinocytes suggested the
functioning of the re-expressed AQP3. The functionality was
confirmed by the demonstration of increased [3H]glycerol
uptake into keratinocytes expressing AQP3 as compared with
those lacking AQP3 (Figure 1b). Similar to these results, Jiang
et al. (Jiang et al., 2011) also demonstrated a significant
increase in glycerol uptake upon an increase in AQP3 levels
following stimulation with agonists of peroxisome proliferator–
activated receptors.
Once our approach was validated, we investigated the
effect of the re-expressed AQP3 on keratinocyte differentiation
and proliferation. However, we suspected that the presence or
absence of AQP3 alone may not be sufficient for observing
changes in various differentiation markers, particularly late
markers, under basal growth conditions. Therefore, to max-
imize the effect of manipulating AQP3 levels, differentiation
markers were examined under basal conditions (50mM cal-
cium) as well as with a moderately increased extracellular
calcium concentration (125mM) to stimulate keratinocyte
differentiation. Previous reports have suggested the impor-
tance of extracellular calcium levels in inducing differentia-
tion, as an increasing concentration gradient of calcium from
the proliferating basal layer to the differentiated granular layer
is observed in the epidermis in situ (Lee et al., 1992; Menon
et al., 1992; Elias et al., 2002). Indeed, low medium calcium
levels promote a basal-like state of the keratinocyte, and
raising the medium calcium concentration triggers keratino-
cyte differentiation (Pillai et al., 1990). Moreover, a calcium
concentration in the range of 90–120mM has been reported to
be optimal for inducing mouse keratinocyte differentiation
(Yuspa et al., 1989; Li et al., 1995). Using a comparable
moderately elevated extracellular calcium concentration, we
demonstrated that re-expression of AQP3 in AQP3-knockout
keratinocytes not only induced a significant increase in the
expression of the early differentiation marker K1 but also
enhanced the effect of this calcium concentration on the
expression of the early differentiation marker, K10, as well as
the late differentiation marker, LOR (Figure 2). The lack of
induction of differentiation markers in the vector-infected,
calcium-treated keratinocytes is likely attributable to the
absence of AQP3 in these keratinocytes. Kim and Lee (2010)
also have reported attenuation of the calcium-induced increase
in the expression of differentiation markers such as K10,
involucrin, and LOR upon siRNA-mediated AQP3 knock-
down in normal human keratinocytes, again suggesting a
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Figure 5. The phospholipase D2 (PLD2)-specific inhibitor, CAY10594,
inhibited the aquaporin 3 (AQP3) re-expression–induced increase in the
protein levels of markers of keratinocyte differentiation. Experiments were
performed as described in Figure 4, and cells were harvested for western
blotting analysis using antibodies against (a) keratin 10 (K10) and (b) loricrin
(LOR). b-Actin served as the loading control. Quantitation of the values from
three independent experiments is shown, with values expressed as the percent
(%) maximal response. **Po0.01, ***Po0.001 versus the vector-infected
control and the other indicated groups; w or #Po0.05, ##Po0.01 versus the
indicated groups.
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requirement for AQP3 in the induction of differentiation.
Another group showed that urea not only increases AQP3
expression but also the mRNA expression of various
differentiation markers (Grether-Beck et al., 2012), also
consistent with the results of this study.
Although several studies support the role of AQP3 in the
proliferation of keratinocytes (Hara-Chikuma et al., 2009;
Nakahigashi et al., 2011; Serna et al., 2014), we did not
observe a significant effect of the presence or absence of
AQP3 on markers of proliferation such as keratin 5 and cyclin
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Figure 6. The lipase-dead (LD) phospholipase D2 (PLD2) mutant, but not LD PLD1, inhibited the aquaporin 3 (AQP3) re-expression–induced increase in the
markers of keratinocyte differentiation. (a–c) AQP3-knockout primary keratinocytes at approximately 70–80% confluence were infected with adenovirus expressing
either wild-type AQP3 or vector using a multiplicity of infection (MOI) of 25 in two groups. One group received additional adenovirus (25 MOI) expressing the LD
PLD2 mutant (PLD2 LD), whereas the other group received adenovirus expressing vector. After 24 hours, fresh medium with basal or an elevated calcium
concentration (125mM) was added to the keratinocytes for an additional 24 hours. The cells were harvested for quantitative real-time reverse-transcriptase–PCR
analysis, and the mRNA expression of (a) keratin 1 (K1), (b) keratin 10 (K10), and (c) loricrin (LOR) was determined using the delta–delta cycle threshold method with
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as the endogenous control. These results are shown as the fold over the vector/vector-infected group and were
derived from at least three independent experiments. ***Po0.001 versus all other groups unless indicated otherwise; ###Po0.001 versus vector/vector; wPo0.05,
wwPo0.01 as indicated. (d–f) AQP3-knockout primary keratinocytes were infected as above, except that an MOI of 12.5 was used both for adenovirus expressing
AQP3 or vector and the additional adenovirus expressing LD PLD1 mutant (PLD1 LD) or vector. The mRNA expression of (d) K1, (e) K10, and (f) LOR was
determined as above. ***Po0.001 versus all other groups unless otherwise indicated; **Po0.01 and *Po0.05 versus vector/vector; wPo0.05, wwPo0.01 as indicated.
NS, nonsignificant. Similar results were obtained in another experiment (repeated once for n¼2) using an MOI of 25 for both viruses (for a total MOI of 50).
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D1 (Figure 3). These results suggest that the AQP3 is a pro-
differentiative signaling protein with no significant role in
proliferation of keratinocytes, at least under the examined
conditions.
We and others have shown that AQP3-mediated transport
of glycerol has a biological role in epidermal differentiation
(Bollag et al., 2007; Bellemere et al., 2008; Qin et al., 2011;
Qin and Bollag, 2013). Therefore, we were interested in
identifying/confirming the downstream signaling factors
involved in the keratinocyte differentiation induced by the
glycerol transported by AQP3. Previously, our laboratory has
shown that AQP3 and PLD2 co-localize in caveolin-rich
membrane microdomains (Zheng and Bollag, 2003). We
have also demonstrated the involvement of this signaling
module in keratinocyte differentiation (Bollag et al., 2007)
and have shown that PLD2 can utilize glycerol in vitro in the
transphosphatidylation reaction to generate phosphatidylgly-
cerol (Zheng et al., 2003). Recently, we have shown that an
agent that decreases phosphatidylglycerol levels (a membrane-
permeant caveolin-1 scaffolding domain peptide) also inhibits
calcium-induced differentiation of mouse keratinocytes (Qin
and Bollag, 2013), suggesting a role for phosphatidylglycerol
in this process. Therefore, we hypothesized that the effect of
re-expression of AQP3 on keratinocyte differentiation might
be mediated by PLD2. Utilizing CAY10594, a PLD2-selective
inhibitor, and a LD PLD2 mutant, we demonstrated inhibition
of the AQP3 re-expression–induced increase in the expression
of differentiation markers upon stimulation of differentiation
with a moderately elevated calcium concentration (Figures 4–6).
However, no inhibitory effect of CAY10594 on AQP3-induced
expression of differentiation markers was observed under
basal, low calcium conditions (Figure 5). This result is likely
due to the fact that, during these experiments, AQP3 was re-
expressed for 24 hours before inhibiting PLD2 (by treating with
CAY10594). Thus, 24 hours seem to be sufficient not only for
re-expressing AQP3 but also for the re-expressed protein to
exert its effect on differentiation. However, in experiments
involving the LD PLD2 mutant, the AQP3 re-expression–
induced increase in K10 expression was inhibited by the
PLD mutant under basal conditions (Figure 6b). In these
experiments, adenovirus expressing LD PLD2 and wild-type
AQP3 were simultaneously infected, and thus LD PLD2 was
able to inhibit AQP3-induced K10 expression. This result is
consistent with our findings of an association between AQP3
and PLD2 in epidermal keratinocytes (Zheng and Bollag,
2003; Zheng et al., 2003). On the other hand, LD PLD1 had
no significant inhibitory effect on the mRNA levels of
differentiation markers (Figure 6d–f) in response to AQP3 re-
expression, suggesting that PLD1 is not involved in AQP3-
induced differentiation of keratinocytes. Thus, the present
results confirmed the involvement of PLD2 in mediating the
role of AQP3 in inducing keratinocyte differentiation.
In summary, we identified a signaling pathway for
keratinocyte differentiation. AQP3, as a glycerol transporter,
allows glycerol to enter the cell and provide this primary
alcohol to associated PLD2. Although we have not eliminated
the possibility of a role for PLD2-generated phosphatidic
acid or other lipid signal in AQP3 re-expression–induced
differentiation, we hypothesize that PLD2 through its trans-
phosphatidylation reaction converts the glycerol to phospha-
tidylglycerol, and phosphatidylglycerol then exerts a
differentiating effect (Bollag et al., 2007). This hypothesis
will be tested in future studies. Finally, the identification of a
differentiative role of AQP3 in keratinocytes suggests the
possibility of targeting this signal to develop treatments for
hyperproliferative skin diseases such as non-melanoma skin
cancers and psoriasis, in which the AQP3 levels and/or
localization are abnormal (Voss et al., 2011; Lee et al.,
2012) and the differentiation process is impaired (Kim and
Lee, 2010; Qin et al., 2011; Sugimoto et al., 2013).
MATERIALS AND METHODS
Materials
Antibodies against proteins of interest were obtained from the
following suppliers: AQP3 (no. B8185; LifeSpan Biosciences, Seattle,
WA); b-actin (no. A5441; Sigma-Aldrich, St Louis, MO); K10 (no.
PRB-159P) and LOR (no. PRB-140C) (Covance, Denver, PA); and
glyceraldehyde-3-phosphate dehydrogenase (GAPDH; no. CB1001;
EMD Millipore, Billerica, MA). AlexaFluor IR680- and IR800-con-
jugated secondary antibodies were from LiCor Biosciences (Lincoln,
NE). Polyvinylidene difluoride membrane was from Millipore
(Billerica, MA), and iScript cDNA synthesis kits were purchased from
Bio-Rad Laboratories (Hercules, CA). The keratinocyte serum-free
medium (K-SFM) containing human recombinant EGF and bovine
pituitary extract (added fresh) was purchased from Life Technologies
(Carlsbad, CA; Cat. no. 7010022). The AQP3-knockout mice were
generously provided by Dr Alan Verkman (University of California,
San Francisco, CA).
Adenoviral constructs amplification
The adenovirus pAdTrack-CMV shuttle vectors were acquired from
Dr Bert Vogelstein (Howard Hughes Medical Institute, Chevy Chase,
MD), and adenovirus-expressing wild-type AQP3 (Zheng and Bollag,
2003) was generated using the AdEasy system as described in the
study by He et al. (1998) and Shapiro et al. ( 2010). The LD PLD2 and
PLD1 mutants were generated as described by Sung et al. (1997).
Amplification of viruses was performed as previously described (Arun
et al., 2013).
Cell culture and experimental design
All animal studies were approved by the Georgia Regents University
Institutional Animal Care and Use Committee. Primary epidermal
mouse keratinocytes were prepared from 1- to 3-day-old neonatal
AQP3-knockout mice (Ma et al., 2002) and seeded in plating medium
as described previously (Jung et al., 1999). After attachment, the
medium was replaced the next day with K-SFM containing 50mM
CaCl2. When the keratinocytes reached 70–80% confluence they
were infected with adenoviruses expressing either vector or wild-type
AQP3 at a multiplicity of infection (MOI) of 25 in K-SFM. In the
experiments involving the PLD2 LD mutant, a total of 50 MOI was
used in all the infected groups with 25 MOI of vector or AQP3-
expressing adenovirus and 25 MOI of vector or LD PLD2 adenovirus.
For PLD1 experiments, an adenovirus concentration of 12.5 MOI
each (for a total of 25 MOI) was used. The virus-containing medium
was removed 24 hours post infection and replaced with K-SFM
containing control (50mM) or an elevated calcium concentration
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(125mM) to stimulate keratinocyte differentiation (Yuspa et al., 1989;
Li et al., 1995). After an additional 24 hours, the cells were harvested
for further analysis. For studies involving the PLD2 inhibitor, the cells
were infected with virus for 24 hours and then treated with
CAY10594 in the presence or absence of an elevated calcium
concentration for 24 hours prior to quantitative real-time reverse-
transcriptase–PCR (qRT–PCR) and western blotting analyses.
Western blotting analysis
At the end of the treatment period, primary keratinocytes were
harvested using hot lysis buffer (0.1875 M Tris-HCl (pH 8.5), 3%
SDS, and 1.5 mM EDTA). The solubilized cells were scraped and
homogenized by repeated pipetting, and 3x sample buffer (30%
glycerol, 15% beta-mercaptoethanol, 1% bromophenol blue, 54%
water) was added prior to boiling the samples. Equal sample volumes
were subjected to SDS-PAGE and then transferred to polyvinylidene
difluoride membranes using a Trans-Blot Turbo Transfer system (Bio-
Rad Laboratories). Membranes were blocked with 5% nonfat dry milk
for at least 30 minutes before incubating with the appropriate
antibodies. Immunoreactivity was visualized and quantified using
infrared imaging on an Odyssey imaging system (LiCor Biosciences).
Quantitative real-time reverse-transcriptase–PCR analysis
Total RNA was extracted using a PerfectPure RNA tissue kit (5 PRIME,
Gaithersburg, MD, USA) as per the manufacturer’s protocol. The
quality and quantity of total RNA were assayed using a Nanodrop
instrument (NanoDrop Technologies, Wilmington, DE). An iScript
cDNA synthesis kit (Bio-Rad Laboratories) was used to reverse
transcribe equal quantities of total RNA (1mg) following the manu-
facturer’s instructions. The cDNA was diluted five times with DNase-
free water, and an equal amount of diluted cDNA was used in qRT–
PCR reactions. Taqman probes were purchased from Applied Biosys-
tems (Life Technologies, Grand Island, NY). qRT–PCR reactions were
performed using the Fast Reagent PCR Master Mix (Applied Biosystems)
and the StepOnePlus Real-Time PCR System (Applied Biosystems) as
per the manufacturer’s protocol. Relative gene expression was calcu-
lated by the delta–delta cycle threshold method using GAPDH and/or
ribosomal protein, large, P0 as endogenous control genes with normal-
ization to the vector (or vector/vector) control group.
[3H]Glycerol uptake assay
To quantify the function of re-expressed AQP3, we performed a
radiolabeled glycerol uptake assay as described in Zheng et al.
(2003). Briefly, after viral infection for 24 hours, the medium was
aspirated and replaced with pre-equilibrated K-SFM containing 20 mM
HEPES and 1mCi ml 1 [3H]glycerol for exactly 5 minutes. The
reactions were terminated, and the excess [3H]glycerol was
removed with three washes of ice-cold PBS lacking divalent
cations. Keratinocytes were solubilized in 0.3 M NaOH, and
aliquots were subjected to liquid scintillation counting.
Statistical analysis
Data from at least three independent experiments are presented as the
means±SEM. An unpaired, two-tailed t-test was used to analyze
differences between two groups. For more than two groups, we
compared group mean values using one-way analysis of variance
with a Newman–Keuls multiple comparison post-hoc test (GraphPad
Prism, La Jolla, CA).
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